• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

L-DAB HBR Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758483

MBS5758483 is an inhibitor targeting L-DAB HBR. L-DAB HBR is an inhibitor of GABA transaminase (IC50 > 500uM). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
L-DAB HBR, Inhibitor
Full Product Name
L-DAB HBR
Product Synonym Names
L-2,4-Diaminobutyric acid
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
118.13
Solubility
H2O: 34mg/mL (287.82mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C4H10N2O2
SMILES
NCC[C@H](N)C(=O)O
CAS Number
1758-80-1
Target & IC50
GABA
Human Endogenous Metabolite
In Vitro
L-2,4-Diaminobutyric acid(DABA) was a non-linear, non-competitive inhibitor of GABA transaminase activity. The DABA-induced elevation of GABA levels paralleled the inhibition of GABA transaminase activity. DABA was a more effective inhibitor of GABA transaminase in vivo than in vitro, and this inhibition probably produced the elevation of GABA levels. The neurotoxicity of DABA appears to produce a use in GABA replacement therapy[1].

Structure of L-DAB HBR, inhibitor

L-DAB HBR Inhibitor – Cat# MBS5758483

Product References and Citations for L-DAB HBR, inhibitor

Beart P M, Bilal K. l-2,4-Diaminobutyric acid and the GABA system[J]. Neuroscience Letters, 1977, 5(3-4):193-198.
Beart P M, Bilal K. l-2,4-Diaminobutyric acid and the GABA system[J]. Neuroscience Letters, 1977, 5(3-4):193-198.
Ronquist G, Hugosson R, Westermark B. Antitumor activity of L-2,4 diaminobuturic acid against mouse fibrosarcoma cells in vitro and in vivo.[J]. Journal of Cancer Research & Clinical Oncology, 1980, 96(3):259-68.
Ronquist G, Hugosson R, Westermark B. Antitumor activity of L-2,4 diaminobuturic acid against mouse fibrosarcoma cells in vitro and in vivo.[J]. Journal of Cancer Research & Clinical Oncology, 1980, 96(3):259-68.

Other Notes

Small volumes of L-DAB HBR, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000